AIM ImmunoTech Inc (AIM)

[Milo2]

From another board:

Ampligen (Rintatolimod) is already approved for human use for chronic fatigue syndrome in Canada, the European Union, and Argentina. It will be easy for these countries to prescribe it off label to save lives and break covid19 transmission. If the Japan and China trials are a success there will be 30 countries already set up to use Ampligen. AIM is way out in front of their competitors like Gilead.